Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Gel4Med is the Smart Materials Company paving the way to the future of regenerative medicine.
Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.
99C manufactures build-to-order apparel for the growing e-commerce market and serves as an economic mobility bridge for the local.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
Micro-Leads Medical is a medical technology company dedicated to developing innovative therapies that address the neuromodulation.
PhagePro is an early-stage biotechnology therapeutics company.
Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.
EnVision Endoscopy is a medical device that provides endoscopic surgeries with solutions.
PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.
Agile Devices is commercializing innovative catheter technologies to reduce procedure time, cost and risk.
Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.
Haystack Dx developed a complete solution to address the clinical unmet need to improve the diagnostic procedure for neuromuscular disorder.
New Equilibrium Biosciences provides a platform that reveals opportunities for structure-based design by learning biophysics with AI.
Snapdragon Chemistry focus on developing practical manufacturing solutions for challenging chemical transformations.
Massachusetts Life Sciences Center has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Massachusetts Life Sciences Center's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Therapeutics. The firm invests across 19 different industry categories.
Among tracked funding rounds, Platelet BioGenesis received $75.5M in a Series B round. Massachusetts Life Sciences Center's total known invested capital is $229.7M.
Massachusetts Life Sciences Center's average investment size is $5.7M across its portfolio of 46 companies.
Recent Massachusetts Life Sciences Center portfolio additions include Aldatu Biosciences, Gel4Med, Decoy Therapeutics, 99degrees Custom, Reveal Pharmaceuticals. These companies were founded in 2020 or later.